A panel selected by FDA Commissioner Marty Makary, MD, MPH, unanimously urged the agency to remove the boxed warning on ...

On Thursday in Washington, D.C., the U.S. Food and Drug Administration (FDA) convened a panel of top experts to reassess the ...

The Food and Drug Administration is reassessing some warnings given about hormone therapy treatments for menopause that have ...

The FDA is reconsidering the black box warning on estrogen. Experts say it’s time for a change—find out what this means for ...

“The role of testosterone is just a lesson in gender bias,” says Kelly Casperson, MD, a urologist. “Because 100 percent of ...

MENOPAUSAL THERAPY IN FOCUS — The FDA will hold a panel discussion Thursday on hormone therapy for menopausal women, a pet ...

By Dennis Thompson HealthDay ReporterMONDAY, July 14, 2025 (HealthDay News) — Good news for women of a certain age: Hormone ...

An Food and Drug Administration expert panel on Thursday endorsed removing the "black box" warning on hormone treatments for ...

A meeting held by the FDA Thursday spotlighted debate over black box warnings that have limited use of hormone treatment for ...

A panel of 12 experts in the menopause field reexamined the findings of the 2002 Women’s Health Initiative study that said ...

Experts worry the warning on vaginal estrogen menopause treatments is doing more harm than good and is not supported by science.

US health authorities are reassessing the risks of Hormone Replacement Therapy (HRT) in a meeting convened by FDA chief Marty ...